Preliminary experiments suggest conolidine may possibly inhibit specific ion channels, reducing neuronal excitability and restricting discomfort signals. This mechanism is particularly applicable in neuropathic pain, wherever abnormal signaling will cause persistent distress. In addition, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to pain notion. ... https://jamesy567zkv0.wikijm.com/user